Endocarditis due to vancomycin-resistant enterococci: Case report and review of the literature

被引:43
作者
Stevens, MP [1 ]
Edmond, MB [1 ]
机构
[1] Virginia Commonwealth Univ, Med Ctr, Richmond, VA 23298 USA
关键词
D O I
10.1086/444459
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Endocarditis due to vancomycin-resistant enterococci (VRE) is rare, and the literature consists almost exclusively of reports of single cases. Methods. We report a case of VRE prosthetic valve endocarditis and review 18 cases of native and prosthetic valve VRE endocarditis reported in the literature. Results. The majority of cases were due to Enterococcus faecium. Nearly all of these infections were hospital acquired, and the vast majority of patients had significant underlying disease processes, including dialysis and transplantation. More than three-quarters of cases were left-sided, and the aortic valve was most commonly involved. Peripheral stigmata of endocarditis were not reported in any of the cases. Approximately 40% of patients developed cardiac complications. Nearly three-quarters of patients survived, despite the difficulties associated with providing bactericidal antimicrobial therapy, and only 4 patients underwent valve replacement. Conclusions. VRE endocarditis is an uncommon nosocomial infection that affects patients with significant comorbid conditions. Most cases are due to E. faecium, and the aortic valve is involved in at least one-half of cases. One-third of patients require surgical treatment. Optimal antimicrobial therapy remains undefined, but an attempt to identify bactericidal combination therapy should be sought.
引用
收藏
页码:1134 / 1142
页数:9
相关论文
共 47 条
[1]   Risk factors for infective endocarditis in patients with enterococcal bacteremia: A case-control study [J].
Anderson, DJ ;
Murdoch, DR ;
Sexton, DJ ;
Reller, LB ;
Stout, JE ;
Cabell, CH ;
Corey, GR .
INFECTION, 2004, 32 (02) :72-77
[2]   Vancomycin-resistant Enterococcus faecium endocarditis in a premature infant successfully treated with linezolid [J].
Ang, JY ;
Lua, JL ;
Turner, DR ;
Asmar, BI .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (12) :1101-1103
[3]  
Archuleta S, 2004, Transpl Infect Dis, V6, P117, DOI 10.1111/j.1399-3062.2004.00059.x
[4]   Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid [J].
Babcock, HM ;
Ritchie, DJ ;
Christiansen, E ;
Starlin, R ;
Little, R ;
Stanley, S .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (09) :1373-1375
[5]   Evaluation of the prevalence and risk factors for colonization by vancomycin-resistant Enterococcus among patients on dialysis [J].
Barbosa, D ;
Lima, L ;
Silbert, S ;
Sader, H ;
Cendoroglo, M ;
Draibe, S ;
Camargo, L ;
Vianna, L ;
Belasco, A ;
Sesso, R .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (02) :337-343
[6]   Linezolid for the treatment of multidrug-resistant, gram-positive infections: Experience from a compassionate-use program [J].
Birmingham, MC ;
Rayner, CR ;
Meagher, AK ;
Flavin, SM ;
Batts, DH ;
Schentag, JJ .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (02) :159-168
[7]   Polymicrobial endocarditis caused by methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococci [J].
Bishara, J ;
Sagie, A ;
Samra, Z ;
Pitlik, S .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (09) :674-675
[8]  
Botha PL, 1998, S AFR MED J, V88, P564
[9]  
Brink AJ, 2000, S AFR MED J, V90, P1113
[10]   National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004 [J].
Cardo, D ;
Horan, T ;
Andrus, M ;
Dembinski, M ;
Edwards, J ;
Peavy, G ;
Tolson, J ;
Wagner, D .
AMERICAN JOURNAL OF INFECTION CONTROL, 2004, 32 (08) :470-485